Generate a tailored SOP for Dr. Putnam Group. Improve your application with a focused, well-structured draft.
The Putnam Lab at Cornell University focuses on the development of functional biomaterials for applications in vaccines and drug delivery biointerfaces. The lab is engineering a new vaccine adjuvant system utilizing bacterially derived outer membrane vesicles (OMVs). Current projects include vaccine solutions that offer protection against influenza and listeria, as well as developing OMVs that target specific effects. In addition, they work on controlled drug delivery systems that enhance targeting to specific cell types, including addressing the blood-brain barrier and targeting chemotherapeutic-resistant cancers. Further research explores the use of biomimetic polymers, including dihydroxyacetone (DHA) and polyethylene glycol (PEG), to create versatile products such as hemostatic agents and synthetic lubricin.
Department of Architecture